Frederick Toth

Frederick Toth started their work experience in 1996 as a Medical Affairs Associate at Wyeth. Frederick then held various roles at sanofi-aventis from 1997 to 2006, including Principal Scientist, Manager, and Senior Manager. In 2006, they joined BioMarin as the Associate Director of Global Safety Services until 2009. From 2009 to 2013, they worked at Celgene as a Senior Manager in Global Drug Safety and Risk Management. Subsequently, they joined Dohmen Life Science Services as the Director of Drug Safety from 2013 to 2015. Frederick then worked at Incyte as part of the Clinical Safety Operations team from 2015 to 2017. Currently, they are the Senior Director of Drug Safety Operations at Nektar Therapeutics, a position they have held since March 2017.

Frederick Toth pursued their Bachelor of Science degree in Pharmacy at Rutgers University from 1977 to 1982. Following this, they attended Seton Hall University from 1991 to 1993, where they obtained a Master's degree in Public Health Administration.